Connect Biopharma Holdings Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 59.5 million compared to USD 118.09 million a year ago. Basic loss per share from continuing operations was USD 1.08 compared to USD 2.15 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 USD | +4.90% | -5.66% | +27.12% |
04-17 | Sector Update: Health Care Stocks Retreating Late Afternoon | MT |
04-17 | Sector Update: Health Care | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.12% | 82.65M | |
+3.91% | 109B | |
+10.87% | 105B | |
+0.20% | 22.25B | |
-13.14% | 22.09B | |
-8.35% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- CNTB Stock
- News Connect Biopharma Holdings Limited
- Connect Biopharma Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023